Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
No.2 Qing Re Jie Du decoction
- Development stage
- Preclinical
- Lead developer
- National Major Science and Technology Projects of China
- Administration
- Oral
01
Overview
No.2 Qing Re Jie Du decoction is a traditional Chinese medicine (TCM) herbal formula, specifically a decoction, designed to 'clear heat and resolve toxicity.' It is being investigated as an intervention for Hand-foot-and-mouth disease (HFMD). As a multi-component herbal preparation, it is believed to exert its therapeutic effects through various mechanisms, including anti-inflammatory, antiviral, and immunomodulatory actions.
- Other names
- Qing-Re Jie-Du decoction清热解毒方2号
02
Targets
IL1A (Interleukin 1 alpha)IL-6 (Interleukin 6)TNFA (Tumor necrosis factor alpha (soluble))
Beyond the preview
Go deeper on No.2 Qing Re Jie Du decoction.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on No.2 Qing Re Jie Du decoction.